Stock Financial Ratios


TNDM / Tandem Diabetes Care, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price2.91
Volume826,700.00
Market Cap ($M)15.15
Enterprise Value ($M)76.05
Book Value ($M)-5.93
Book Value / Share-0.19
Price / Book-0.53
NCAV ($M)80.92
NCAV / Share2.65
Price / NCAV-0.25
Income Statement (mra) ($M)
Revenue84.25
EBITDA-78.05
Net Income-83.45
Balance Sheet (mrq) ($M)
Cash & Equivalents12.08
Cash / Share0.40
Assets87.98
Liabilities115.94
Quick Ratio2.25
Current Ratio2.93
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.11
Return on Assets (ROA)-0.74
Return on Equity (ROE)14.08
Identifiers and Descriptors
CUSIP875372104
Central Index Key (CIK)1438133
Industry Groups
SIC 3841 - Surgical and Medical Instruments and Apparatus
Other Related CUSIPS
875372954
875372904
Share Statistics
Common Shares Outstanding (M)10.12
Scoring Models
Piotroski F Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Work In Progress Per Share0.00
Long Term Debt Per Share0.00
Cash Per Share0.40
Treasury Stock Per Share0.00
Accounts Receivable Per Share0.35
Accounts Payable Per Share0.00
Property Plant And Equipment Net Per Share0.66
Debt Per Share0.00
Liabilities Other Non Current Per Share0.22
Retained Earnings Per Share-15.25
Intangibles Per Share0.00
Inventory Raw Materials Per Share0.33
Additional Paid In Capital Per Share14.33
Goodwill Per Share0.00
Liabilities Current Per Share0.96
Equity Per Share-0.91
Liabilities And Stock Equity Per Share2.88
Inventory Per Share0.98
Deferred Income Tax Liabilities Per Share0.00
Liabilities Per Share3.79
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Assets Current Per Share1.83
Cash And Equivalents Per Share0.40
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.47
Property Plant And Equipment Per Share0.66
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Assets Per Share2.88
Accumulated Depreciation And Depletion Per Share0.00
Minority Interest Per Share0.00
Assets Other Non Current Per Share0.01

Related News Stories

Tandem Diabetes Care -  Speculative Turnaround Play With Huge Potential

2018-01-11 seekingalpha
Company issued very strong preliminary Q4/2017 results and guided for 2018 revenue growth of roughly 35%. (29-2)

Stocks To Watch: CES Headlines Blockbuster Conference Slate

2018-01-06 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (861-8)

Innovation in diabetes care in 2017 will continue in 2018

2017-12-29 cnbc
Companies are racing to develop technology that makes it easier and simpler for the estimated 30.3 million Americans with diabetes to manage their blood sugar. About 9 percent of the population has the disease, according to the Centers for Disease Control and Prevention. (24-1)

New Year to Bring Back MedTech Tax, 3 Stocks Unfazed

2017-12-27 zacks
The infamous medical device excise tax will be back in effect starting Jan 1, 2018. The 2.3% medical device tax dealt a heavy blow to the U.S. MedTech space, since its enactment in 2013. However, a temporary two-year moratorium from 2015 to 2017 raised hopes for stakeholders. But, 2018 might not be a cakewalk for the MedTech companies and investors, considering the re-enactment of the taxes. (35-0)

Insider Buying: Tandem Diabetes Care, Inc. (TNDM) CEO Buys $999,950.00 in Stock

2017-10-20 thecerbatgem
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) CEO Kim D. Blickenstaff acquired 285,700 shares of Tandem Diabetes Care stock in a transaction that occurred on Friday, October 13th. The shares were bought at an average price of $3.50 per share, with a total value of $999,950.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. (41-6)

CUSIP: 875372104